Teva, Sanofi present new results from RELIEVE UCCD Phase 2b study
Teva Pharmaceuticals (TEVA), and Sanofi (SNY) presented new, detailed results from the RELIEVE UCCD Phase 2b study of duvakitug, a human IgG1-2 ...
EU regulators clear aid for Engie's Belgian nuclear reactors
EU competition regulators on Friday approved Belgium's plan to grant state aid to French energy company Engie's Belgian unit ...
EU approves state aid to extend life of Engie's Belgian nuclear reactors
EU competition regulators on Friday approved Belgium's plan to grant state aid to French energy company Engie's Belgian ...
Sanofi treatment of autoimmune hemolytic anemia granted orphan status
The FDA granted orphan designation to Sanofi ( SNY) US Services’ rilzabrutinib as a treatment of autoimmune hemolytic anemia, according to a post to the agency’s website. Published first on TheFly – ...
BioPharma Dive4d
Sanofi reaches consumer health deal; Supernus antidepressant fails study
The pharma signed an agreement handing PE firm CD&R a 50% stake in its Capella unit. Elsewhere, Gilead and Ultragenyx secured ...
Sanofi to sell 50% stake in consumer health unit to CD&R
Sanofi ( NASDAQ: SNY) has entered a share purchase agreement in relation to the sale of a 50% controlling stake in Opella, ...